Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor
Clinical trial NCT01603212 · COMPLETED
Trial details
- NCT number
- NCT01603212
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-18
- Primary completion
- 2017-07-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.